| Gene symbol | IL3RA | Synonyms | CD123, IL-3R-alpha, IL3R, IL3RAY, IL3RX, IL3RY, hIL-3Ra | Type of gene | protein-coding |
| Chromosome | X|Y | Map location | X;Y | dbXrefs | |
| Description | interleukin 3 receptor subunit alpha | ||||
| GTO ID | GTC0781 |
| Trial ID | ChiCTR1800020211 |
| Disease | Acute Lymphoblastic Leukemia |
| Altered gene | CD123 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CD123 CAR-T cells |
| Phase | Phase1 |
| Recruitment status | Not Recruiting |
| Title | Phase I study for autologous anti-CD123 (human derived) chimeric antigen receptor T cells treating refractory or relapsed acute lymphoblastic leukemia |
| Year | 2018 |
| Country | China |
| Company sponsor | Beijing Boren Hospital |
| Cohort 1 | |||||||
|
|||||||